{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T12:13:14Z","timestamp":1783944794080,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.clgc.2026.102576","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T15:51:06Z","timestamp":1777996266000},"page":"102576","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Preoperative Risk Stratification Approach Using the Focal Risk Group (FRG) in Patients Undergoing Focal Therapy for Localized Prostate Cancer"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7586-4132","authenticated-orcid":false,"given":"Umberto","family":"Anceschi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5944-5637","authenticated-orcid":false,"given":"Salvatore","family":"Basile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Mastroianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1140-0590","authenticated-orcid":false,"given":"Eugenio","family":"Bologna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"D\u2019Annunzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3274-1247","authenticated-orcid":false,"given":"Leslie Claire","family":"Licari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Iannuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Cartolano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3505-197X","authenticated-orcid":false,"given":"Giulia","family":"Atzu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Tufano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Misuraca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costantino","family":"Leonardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Lugnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.clgc.2026.102576_bib0001","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/jama.2025.0228","article-title":"Prostate cancer: a review","volume":"333","author":"Raychaudhuri","year":"2025","journal-title":"JAMA"},{"issue":"17","key":"10.1016\/j.clgc.2026.102576_bib0002","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2214122","article-title":"Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer","volume":"388","author":"Hamdy","year":"2023","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.clgc.2026.102576_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.clgc.2023.04.013","article-title":"An update on focal therapy for prostate cancer","volume":"21","author":"Ayerra Perez","year":"2023","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.clgc.2026.102576_bib0004","doi-asserted-by":"crossref","DOI":"10.1177\/11795549251350830","article-title":"Current status of cryoablation in prostate cancer management","volume":"19","author":"Karwacki","year":"2025","journal-title":"Clin Med Insights Oncol"},{"issue":"17","key":"10.1016\/j.clgc.2026.102576_bib0005","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17172863","article-title":"Oncological efficacy and safety of minimally invasive focal and whole-gland interventions in the treatment of low- and intermediate-risk prostate cancer: a systematic review and meta-analysis","volume":"17","author":"Skribek","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.clgc.2026.102576_bib0006","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1097\/JU.0000000000000456","article-title":"Hemigland cryoablation of localized low, intermediate and high risk prostate cancer: oncologic and functional outcomes at 5 years","volume":"202","author":"Oishi","year":"2019","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.clgc.2026.102576_bib0007","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/bju.16213","article-title":"Focal therapy with high-intensity focused ultrasound for prostate cancer: 3-year outcomes from a prospective trial","volume":"133","author":"Kaufmann","year":"2024","journal-title":"BJU Int"},{"issue":"17","key":"10.1016\/j.clgc.2026.102576_bib0008","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17172762","article-title":"Tailoring treatment in localized prostate cancer: comparative effectiveness of HIFU, cryoablation, and robot-assisted radical prostatectomy at 2-year follow-up: insights from prospective institutional cohort","volume":"17","author":"Anceschi","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.clgc.2026.102576_bib0009","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11934-024-01211-x","article-title":"Focal therapy in grade group 3 prostate cancer","volume":"25","author":"Pressler","year":"2024","journal-title":"Curr Urol Rep"},{"issue":"2","key":"10.1016\/j.clgc.2026.102576_bib0010","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.euf.2024.11.005","article-title":"Survival outcomes and recurrence patterns following focal high-intensity focused ultrasound treatment for localized prostate cancer: insights on patient selection and lessons learned","volume":"11","author":"Nahar","year":"2025","journal-title":"Eur Urol Focus"},{"issue":"5","key":"10.1016\/j.clgc.2026.102576_bib0011","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.eururo.2024.11.006","article-title":"Whole-gland or subtotal high-intensity focused ultrasound versus radical prostatectomy: the prospective, noninferiority, nonrandomized HIFI trial","volume":"87","author":"Ploussard","year":"2025","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.clgc.2026.102576_bib0012","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer-2024 update. Part I: screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.clgc.2026.102576_bib0013","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41391-024-00875-3","article-title":"Salvage treatments after focal therapy for prostate cancer: a comprehensive review","volume":"28","author":"Storino Ramacciotti","year":"2025","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"2","key":"10.1016\/j.clgc.2026.102576_bib0014","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/bju.16746","article-title":"Perioperative complications of focal therapy for prostate cancer: results from the GeRmAn Nationwide inpatient Data (GRAND) study","volume":"136","author":"Pyrgidis","year":"2025","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.clgc.2026.102576_bib0015","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.euo.2025.02.003","article-title":"Outcomes of Focal therapy for localized prostate cancer: a systematic review and meta-analysis of prospective studies","volume":"8","author":"\u015alusarczyk","year":"2025","journal-title":"Eur Urol Oncol"},{"issue":"5","key":"10.1016\/j.clgc.2026.102576_bib0016","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.eururo.2016.08.065","article-title":"The CAPRA score at 10 years: contemporary perspectives and analysis of supporting studies","volume":"71","author":"Brajtbord","year":"2017","journal-title":"Eur Urol"},{"issue":"9","key":"10.1016\/j.clgc.2026.102576_bib0017","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1159\/000477545","article-title":"Heterogeneity of outcomes in D\u2019Amico intermediate-risk prostate cancer patients after radical prostatectomy: influence of primary and secondary gleason score","volume":"40","author":"Pollard","year":"2017","journal-title":"Oncol Res Treat"},{"issue":"3","key":"10.1016\/j.clgc.2026.102576_bib0018","doi-asserted-by":"crossref","first-page":"140","DOI":"10.6004\/jnccn.2024.0019","article-title":"Prostate Cancer, version 3.2024 featured updates to the NCCN Guidelines","volume":"22","author":"Schaeffer","year":"2024","journal-title":"JNCCN J Natl Compr Cancer Netw"},{"issue":"1","key":"10.1016\/j.clgc.2026.102576_bib0019","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/pros.24800","article-title":"Prostate cancer focal therapy: surgeon experience influences oncological results","volume":"85","author":"Murta","year":"2025","journal-title":"Prostate"},{"issue":"3","key":"10.1016\/j.clgc.2026.102576_bib0020","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/JU.0000000000003569","article-title":"Biopsy assessment of oncologic control 3 years following primary partial gland cryoablation: a prospective cohort study of men with intermediate-risk prostate cancer","volume":"210","author":"Wysock","year":"2023","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.clgc.2026.102576_bib0021","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00345-026-06378-1","article-title":"Hemigland cryoablation versus high-intensity focused ultrasound for localized prostate cancer: a propensity-weighted comparison of functional and oncologic outcomes","volume":"44","author":"Anceschi","year":"2026","journal-title":"World J Urol"},{"issue":"3","key":"10.1016\/j.clgc.2026.102576_bib0022","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3390\/biomedicines14030716","article-title":"Predicting 1-year trifecta outcomes after high-intensity focused ultrasound and cryoablation for low- and intermediate-risk prostate cancer","volume":"14","author":"Anceschi","year":"2026","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.clgc.2026.102576_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.clgc.2026.102520","article-title":"Predictors of early and late oncologic failure after primary prostate cryoablation for localized prostate cancer","volume":"24","author":"Basile","year":"2026","journal-title":"Clin Genitourin Cancer"},{"issue":"1","key":"10.1016\/j.clgc.2026.102576_bib0024","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/EDE.0b013e3181c30fb2","article-title":"Assessing the performance of prediction models: a framework for traditional and novel measures","volume":"21","author":"Steyerberg","year":"2010","journal-title":"Epidemiology"},{"key":"10.1016\/j.clgc.2026.102576_bib0025","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jclinepi.2019.02.004","article-title":"A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models","volume":"110","author":"Christodoulou","year":"2019","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"10.1016\/j.clgc.2026.102576_bib0026","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.eururo.2014.06.024","article-title":"Guidelines for reporting of statistics in european urology","volume":"67","author":"Vickers","year":"2015","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.clgc.2026.102576_bib0027","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/bju.14640","article-title":"Guidelines for reporting of statistics for clinical research in urology","volume":"123","author":"Assel","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2026.102576_bib0028","article-title":"Uncertainty of risk estimates from clinical prediction models: rationale, challenges, and approaches","volume":"388","author":"Riley","year":"2025","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.clgc.2026.102576_bib0029","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/s41391-023-00699-7","article-title":"Oncological results and cancer control definition in focal therapy for prostate cancer: a systematic review","volume":"27","author":"Nicoletti","year":"2024","journal-title":"Prostate Cancer Prostatic Dis"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767326000765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767326000765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T11:52:21Z","timestamp":1783943541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767326000765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1558767326000765"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2026.102576","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Preoperative Risk Stratification Approach Using the Focal Risk Group (FRG) in Patients Undergoing Focal Therapy for Localized Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2026.102576","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102576"}}